MalarVx is a bio-pharmaceutical company located in Seattle, Washington. We founded MalarVx to address the myriad challenges of creating a safe, affordable, effective malaria vaccine using innovative new technologies discovered through research.  It is our passion to bring these solutions out of the lab and to the millions of people who need them. We collaborate with researchers in non-profit institutions, university infectious disease programs, foundations committed to solving diseases of the third world, and for-profit pharmaceutical companies.